“…With each of these drugs, at doses that produce taste avoidance equivalent to that produced by lithium, none has been shown to produce rejection reactions in the TR test. On the other hand, as is depicted in the upper right-hand quadrant of Table 1, across a wide range of doses, a number of drugs that produced place and taste avoidance also produced rejection reactions, including novel alcohol (Cunningham, 1979;B. T. Davies & Parker, 1990), chlordiazepoxide (Parker, Limebeer, & Simpson, 1998), cyclophosphamide (Parker, 1998), fenfluramine (A. M. Davies & Parker, 1993;Parker, 1988), lithium chloride (Berridge et al, 1981;Grill & Norgren, 1978;Mucha et al, 1982;Parker, 1982Parker, , 1992Pelchat et al, 1983), and naloxone-precipitated morphine withdrawal (Mc-Donald et al, 1997;Parker & Joshi, 1998).…”